Document is current
Any future updates will be listed below
-
Authors
Ohsawa, Shin
Schwaiger, Michaela
Iesmantavicius, Vytautas
Hashimoto, Rio
Moriyama, Hiromitsu https://orcid.org/0000-0001-7678-8015
Matoba, Hiroaki https://orcid.org/0000-0002-7063-9403
Hirai, Go https://orcid.org/0000-0003-3420-555X
Sodeoka, Mikiko https://orcid.org/0000-0002-1344-364X
Hashimoto, Atsushi
Matsuyama, Akihisa https://orcid.org/0000-0002-6135-6276
Yoshida, Minoru https://orcid.org/0000-0002-4376-5674
Yashiroda, Yoko https://orcid.org/0000-0003-3279-141X
Bühler, Marc https://orcid.org/0000-0001-6661-9795
-
Funding
Funding for this research was provided by:
Friedrich Miescher Institute for Biomedical Research
MEXT | Japan Society for the Promotion of Science (18H02131)
MEXT | Japan Society for the Promotion of Science (22K05397)
MEXT | Japan Society for the Promotion of Science (19K15755)
MEXT | Japan Society for the Promotion of Science (23H05473)
MEXT | Japan Society for the Promotion of Science (23H04882)
Ohsumi Frontier Science Foundation (na)
Novartis Research Foundation
- License Information
-
More Information
Article History
Received: 1 March 2024
Revised: 8 August 2024
Accepted: 16 August 2024
First Online: 10 September 2024
Disclosure and competing interests statement
: The Friedrich Miescher Institute for Biomedical Research (FMI) receives significant financial contributions from the Novartis Research Foundation. Published research reagents from the FMI are shared with the academic community under a Material Transfer Agreement (MTA) having terms and conditions corresponding to those of the UBMTA (Uniform Biological Material Transfer Agreement).
